Close Menu

Play It Safe

The way grants are doled out leads researchers to play it safe -- and that's why there has been little progress in the "war on cancer," writes Gina Kolata in the New York Times. Incremental research is chosen by reviewers because "with too little money to finance most proposals, they are timid about taking chances on ones that might not succeed," Kolata writes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.